IL-10 and TNF-β gene polymorphisms have no major influence on lactate levels after cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 1, 2006, Pages 54-58

  Riha, Hynek ^a,b   Hubacek, Jaroslav A ^a,b   Poledne, Rudolf ^a,b   Kellovsky, Pavel ^a   Brezina, Ales ^a   Pirk, Jan ^a,b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Cardiovascular Research Center   (Czech Republic)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Genetics; Inflammatory mediators; Inflammatory response; Lactic acid

Indexed keywords

INTERLEUKIN 10; LACTIC ACID; LYMPHOTOXIN;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART DISEASE; HEART LEFT VENTRICLE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION MAPPING; SURGICAL PATIENT;

ADULT; AGED; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LACTIC ACID; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 33744929906     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.02.025     Document Type: Article

References (16)

1. Wan S., LeClerc J.L., and Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112 (1997) 676-692
2. Cremer J., Martin M., Redl H., Bahrami S., Abraham C., Graeter T., Haverich A., Schlag G., and Borst H.G. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 61 (1996) 1714-1720
3. Chiolero R.L., Revelly J.P., Leverve X., Gersbach P., Cayeux M.C., Berger M.M., and Tappy L. Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery. Crit Care Med 28 (2000) 3784-3791
4. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor family. N Engl J Med 334 (1996) 1717-1785
5. Vary T., Hazen S., Maish G., and Cooney R. TNF binding protein prevents hyperlactaemia and inactivation of PDH complex in skeletal muscle during sepsis. J Surg Res 80 (1998) 44-51
6. Hall R.I., Smiths M.S., and Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85 (1997) 766-782
7. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
8. Tomasdottir H., Hjartarson H., Ricksten A., Wasslavik C., Bengtsson A., and Ricksten S.E. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 97 (2003) 944-949
9. Gru{combining double acute accent}nenfelder J., Umbehr M., Plass A., Bestmann L., Maly F.E., Zu{combining double acute accent}nd G., and Turina M. Genetic polymorphism of apolipoprotein E4 and tumor necrosis factor β as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. J Thorac Cardiovasc Surg 128 (2004) 92-97
10. Ryan T., Balding J., McGovern E.M., Hinchion J., Livingstone W., Chughtai Z., and Smith O.P. Lactic acidosis after cardiac surgery is associated with polymorphism in tumor necrosis factor and interleukin 10 genes. Ann Thorac Surg 73 (2002) 1905-1911
11. Inoue S., Kuro M., and Furuya H. What factors are associated with hyperlactatemia after cardiac surgery characterized by well-maintained oxygen delivery and a normal postoperative course? A retrospective study. Eur J Anaesthesiol 18 (2001) 576-584
12. Day I.N., and Humphries S.E. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 222 (1994) 389-395
13. Jansen P., Baufreton C., Le Besnerais P., Loisance D.Y., and Wildevuur C.R. Heparin coated circuits and aprotinin prime for coronary artery bypass grafting. Ann Thorac Surg 61 (1996) 1363-1366
14. Alderman E.L., Levy J.H., Rich J.B., Nili M., Vidne B., Schaff H., Uretzky G., Pettersson G., Thiis J.J., Hantler C.B., Chaitman B., and Nadel A. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) Trial. J Thorac Cardiovasc Surg 116 (1998) 716-730
15. Lord R.A., Roath O.S., Thompson J.F., Chant A.D., and Francis J.L. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg 79 (1992) 517-521
16. Koch W., Kastrati A., Böttiger C., Mehilli J., Beckerath von N., and Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159 (2001) 137-144